Jack Anders
CIK: 0001800668
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Revolution Medicines, Inc.
Discretionary Trading P&L
Holdings
Transaction History (31 total)
- Sep 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct4K shares at avg. $199.30$796K - Sep 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct61 shares at avg. $195.00$12K - Jun 24, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct9.5K shares at avg. $168.20$1.6M - Jun 24, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct5.7K shares at avg. $169.24$956K - Jun 24, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct300 shares at avg. $170.32$51K - Jun 24, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct20K shares at avg. $18.56$371K - Jun 24, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct4.6K shares at avg. $167.34$762K - Jun 16, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct2.7K shares at avg. $156.12$425K - Mar 17, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct2.8K shares at avg. $99.48$274K - Mar 1, 2026RVMD
Revolution Medicines, Inc.
Award(A)Direct20.2K shares- - Jan 7, 2026RVMD
Revolution Medicines, Inc.
Sale(S)Direct10K shares at avg. $98.00$980K - Jan 7, 2026RVMD
Revolution Medicines, Inc.
Exercise(M)Direct10K shares at avg. $42.45$425K - Dec 16, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct3.1K shares at avg. $77.09$239K - Nov 25, 2025RVMD
Revolution Medicines, Inc.
Exercise(M)Direct5.4K shares at avg. $17.00$92K - Nov 25, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct5.4K shares at avg. $74.00$401K - Nov 11, 2025RVMD
Revolution Medicines, Inc.
Exercise(M)Direct10K shares at avg. $17.00$170K - Nov 11, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct10K shares at avg. $64.00$640K - Sep 16, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct2.3K shares at avg. $45.82$106K - Sep 3, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct5.2K shares at avg. $40.17$210K - Sep 3, 2025RVMD
Revolution Medicines, Inc.
Exercise(M)Direct2K shares at avg. $17.00$35K - Sep 3, 2025RVMD
Revolution Medicines, Inc.
Exercise(M)Direct3.2K shares at avg. $4.73$15K - Sep 2, 2025RVMD
Revolution Medicines, Inc.
Exercise(M)Direct2.8K shares at avg. $2.68$8K - Sep 2, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct4.8K shares at avg. $40.02$191K - Sep 2, 2025RVMD
Revolution Medicines, Inc.
Exercise(M)Direct1.9K shares at avg. $4.73$9K - Jun 16, 2025RVMD
Revolution Medicines, Inc.
Sale(S)Direct2.2K shares at avg. $39.83$86K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 3,992 | $199.30 | $795,618 | Direct |
| Sep 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 61 | $195.00 | $11,895 | Direct |
| Jun 24, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 9,496 | $168.20 | $1,597,188 | Direct |
| Jun 24, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 5,651 | $169.24 | $956,398 | Direct |
| Jun 24, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 300 | $170.32 | $51,096 | Direct |
| Jun 24, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 20,000 | $18.56 | $371,200 | Direct |
| Jun 24, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 4,553 | $167.34 | $761,922 | Direct |
| Jun 16, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,722 | $156.12 | $424,956 | Direct |
| Mar 17, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,753 | $99.48 | $273,870 | Direct |
| Mar 1, 2026 | RVMD Revolution Medicines, Inc. | Award(A) | 20,200 | - | $0 | Direct |
| Jan 7, 2026 | RVMD Revolution Medicines, Inc. | Sale(S) | 10,000 | $98.00 | $980,000 | Direct |
| Jan 7, 2026 | RVMD Revolution Medicines, Inc. | Exercise(M) | 10,000 | $42.45 | $424,500 | Direct |
| Dec 16, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 3,104 | $77.09 | $239,289 | Direct |
| Nov 25, 2025 | RVMD Revolution Medicines, Inc. | Exercise(M) | 5,418 | $17.00 | $92,106 | Direct |
| Nov 25, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 5,418 | $74.00 | $400,932 | Direct |
| Nov 11, 2025 | RVMD Revolution Medicines, Inc. | Exercise(M) | 10,000 | $17.00 | $170,000 | Direct |
| Nov 11, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 10,000 | $64.00 | $640,000 | Direct |
| Sep 16, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,320 | $45.82 | $106,314 | Direct |
| Sep 3, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 5,238 | $40.17 | $210,432 | Direct |
| Sep 3, 2025 | RVMD Revolution Medicines, Inc. | Exercise(M) | 2,049 | $17.00 | $34,833 | Direct |
| Sep 3, 2025 | RVMD Revolution Medicines, Inc. | Exercise(M) | 3,189 | $4.73 | $15,084 | Direct |
| Sep 2, 2025 | RVMD Revolution Medicines, Inc. | Exercise(M) | 2,814 | $2.68 | $7,542 | Direct |
| Sep 2, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 4,762 | $40.02 | $190,560 | Direct |
| Sep 2, 2025 | RVMD Revolution Medicines, Inc. | Exercise(M) | 1,948 | $4.73 | $9,214 | Direct |
| Jun 16, 2025 | RVMD Revolution Medicines, Inc. | Sale(S) | 2,170 | $39.83 | $86,431 | Direct |
1-25 of 31 transactions
About Anders Jack
Anders Jack (SEC CIK 0001800668) files insider reports with the SEC as Chief Financial Officer of Revolution Medicines, Inc. (RVMD).
Signal8 holds 17 ownership filings by Anders Jack, all Form 4s, filed between Sep 18, 2024 and Sep 18, 2026. Those filings report 31 transactions, from Sep 16, 2024 to Sep 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Anders Jack's filings is in REDWOOD CITY, CA.
Recent filings by Anders Jack
- Sep 16, 2026: Open-market sales of RVMD shares (2 lines, Form 4, code S).
- Jun 24, 2026: Open-market sales of RVMD shares (3 lines, Form 4, code S).
- Jun 24, 2026: Option exercise of RVMD shares (Form 4, code M).
- Jun 24, 2026: Open-market sale of RVMD shares (Form 4, code S).
- Jun 16, 2026: Open-market sale of RVMD shares (Form 4, code S).
Other insiders filing for Revolution Medicines, Inc. (RVMD)
- Mancini Anthony
- Sandler Alan B., Chief Development Officer
- Cislini Jeff, SVP & General Counsel
- ANDERSON ELIZABETH M, Director
- Kelsey Stephen Michael
- Horn Margaret A, Chief Operating Officer